Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000064782-06-000100
Filing Date
2006-06-12
Accepted
2006-06-09 20:23:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 oncolytics200605mfc.txt SC 13G/A 16286
  Complete submission text file 0000064782-06-000100.txt   18357
Mailing Address
Business Address ONE MELLON BANK CTR 500 GRANT ST PITTSBURGH PA 15258-0001 4122345000
MELLON FINANCIAL CORP (Filed by) CIK: 0000064782 (see all company filings)

EIN.: 251233834 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Subject) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-77907 | Film No.: 06898242
SIC: 2834 Pharmaceutical Preparations